SCHEMBL1415802

SCHEMBL1415802

CCn1c2ccccc2c(=O)c2cc3c(cc21)c(=O)c1ccccc1n3CCCCCC(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 3/20 0.64
FABP5 Q01469 3/20 0.64
ALDH1A1 P00352 1/20 0.56
SLC6A4 P31645 2/20 0.53
SLC6A2 P23975 1/20 0.53
HRH1 P35367 1/20 0.53
HDAC1 Q13547 3/20 0.51
HDAC6 Q9UBN7 3/20 0.51
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC9 Q9UKV0 1/20 0.51
HDAC5 Q9UQL6 1/20 0.51
PSEN1 P49768 4/20 0.50
PSEN2 P49810 4/20 0.50
APH1B Q8WW43 4/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL355352 0.88 FABP4 (0.82) FABP4FABP5SLC6A4SLC6A2HRH1
SCHEMBL353478 0.83 FABP4 (0.64) FABP4FABP5SLC6A4SLC6A2HRH1
SCHEMBL354539 0.83 FABP4 (0.64) FABP4FABP5ALDH1A1SLC6A4SLC6A2
SCHEMBL354562 0.83 FABP4 (0.64) FABP4FABP5SLC6A4SLC6A2HRH1
SCHEMBL1401219 0.83 FABP4 (0.45) FABP4FABP5ALDH1A1PSEN1PSEN2
SCHEMBL353874 0.82 FABP4 (0.60) FABP4FABP5HDAC1HDAC6HDAC3
SCHEMBL14493937 0.82 SLC6A4 (0.63) ALDH1A1SLC6A4SLC6A2HRH1PSEN1
SCHEMBL14493934 0.82 SLC6A4 (0.63) ALDH1A1SLC6A4SLC6A2HRH1PSEN1
SCHEMBL6419189 0.81 FABP4 (0.97) FABP4FABP5ALDH1A1HDAC1HDAC6
SCHEMBL6833930 0.81 FABP4 (0.97) FABP4FABP5ALDH1A1HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399742-B1 QUINACRIDONE LABELLING REAGENTS FOR FLUORESCENCE DETECTION OF BIOLOGICAL MATERIALS GE HEALTHCARE UK LTD (GB) 2011-03-16 EP disclosed
US-7335771-B2 Quinacridone derivatives as labelling reagents for fluorescence detection of biological materials GE HEALTHCARE UK LIMITED (GB) 2008-02-26 US disclosed
US-20040171014-A1 Quinacridone derivatives as labelling reagents for flurescence detection of bilogical materials TTP LABTECH LIMITED (GB) 2004-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171014-A1 Quinacridone derivatives as labelling reagents for flurescence detection of bilogical materials Q6ZSR9, MPHOSPH6, NQO2 FABP4 933/4885FABP5 390/4885ALDH1A1 1429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.